News

The latest on managing care, value-based care, insurance markets, payers & providers

NCQA To Judge Plans on Drug Monitoring

Health plans could soon be required to develop systems to prevent drug interactions, as well as systems to monitor drug recalls and FDA alerts, under proposed accreditation standards issued recently by the National Committee for Quality Assurance.

In the event of such problems, the health plans would then have to alert pharmacists, patients, and providers.

Plans are uniquely positioned to do this, says NCQA spokesman Brian Schilling, because claims information contains pharmaceutical data.

"Health plans, of course, are involved in the process of developing accreditation standards, so I think that if they felt that this wasn't doable, we would have heard by now that it's not feasible," Schilling says.

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.